NCT03899389View on ClinicalTrials.gov

Plasma TMAO (Trimethylamine N-oxide) as a Predictive Marker in Coronary Disease Patients

CompletedOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

February 1, 2017

Primary Completion Date

May 31, 2018

Study Completion Date

May 31, 2018

Conditions
Coronary Disease
Interventions
DIAGNOSTIC_TEST

plasma samples collection

Trimethylamine N-oxide (TMAO) concentration will be determined in plasma samples

Trial Locations (1)

80-336

University of Physical Education and Sport, Gdansk

All Listed Sponsors
lead

Gdansk University of Physical Education and Sport

OTHER

NCT03899389 - Plasma TMAO (Trimethylamine N-oxide) as a Predictive Marker in Coronary Disease Patients | Biotech Hunter | Biotech Hunter